Lupus patients have been waiting a while for some good news. Only one drug, belimumab (Benlysta), has been FDA-approved for lupus in more than 50 years — and that happened back in 2011. Since then,…
fibromyalgia warriors
Celebrate the resilience of Fibromyalgia warriors, sharing stories of strength, tips for managing symptoms, and resources for support and empowerment.
Nearly Half of Giant Cell Arteritis Patients on Actemra for a Year Stay in Remission After Stopping It
“Giant cell arteritis requires ongoing management, but it does not necessarily require continuous treatment.” In 2017, tocilizumab (Actemra), a biologic drug that inhibits interleukin-6 (IL-6), was FDA-approved for giant cell arteritis — an inflammation of…
Vagus Nerve Stimulation: A New Way to Treat Rheumatoid Arthritis
Some people with rheumatoid arthritis (RA) take a disease-modifying antirheumatic drug (DMARD) and/or a biologic and reach remission. Others try drug after drug after drug and never find one that’s effective — or that treats…
Taking Hydroxychloroquine for RA or Lupus Can Reduce Heart Risk by 17%
The anti-malarial drug lowers cholesterol and blood sugar makes blood less sticky, which is good for reducing blood clots and heart attack risk. If you take the anti-malarial drug hydroxychloroquine (Plaquenil) as part of your…
More Than 75% of Arthritis Patients Don’t Get Hepatitis Screening Before Starting a Biologic
Screening is important because silent hepatitis B and C infections can spring to life when you start biologics or new synthetic DMARDs. Before you start taking a biologic drug or one of the new targeted…
Could the Weather Affect Lupus Symptoms? New Study Suggests Warm, Humid Weather Does
As the temperature increased, so did the risk of rash, joint inflammation, kidney problems, and other lupus symptoms. Shifts in weather patterns have long been associated with a variety of health ailments, from seasonal allergies…
If You’re in Remission on a DMARD for Rheumatoid Arthritis, Should You Taper? Here’s What New Research Says
New data compares what happens when the dosage of DMARDs such as methotrexate is tapered or kept steady. For most rheumatoid arthritis (RA) patients, sustained remission (inactive disease) is the goal of taking methotrexate or…
Good News for Pregnant Women with Arthritis: Most Babies Exposed to Biologics in Utero Don’t Get Serious Infections
Although biologics cross the placenta, research shows they lead to few infections in babies after they’re born. The prospect of pregnancy can be daunting for women with inflammatory arthritis. Not only can disease flares occur,…
Here’s More Data That Suggests We Shouldn’t Use Opioids to Treat Osteoarthritis Pain
Surprisingly, stronger opioids were the worst at relieving pain in a new multi-study analysis. Despite concerns about safety and addiction, lots of people with osteoarthritis (OA) take opioids to address their chronic pain. A recent…
This Is Important for RA Patients to Know: Taming Inflammation Doesn’t Always Alleviate Pain
“This may have implications for management decisions beyond treating to disease activity targets alone.” Pain and inflammation often go hand in hand, especially for people with inflammatory conditions like rheumatoid arthritis (RA). So it logically…